Valeant Pharmaceuticals International, Inc. (VRX)
Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients. Valeant’s development pipeline strategy comprises both new compounds as well as product life cycle management. Its early and late-stage drug candidates have unique formulations and mechanisms of action including retigabine for the treatment of epilepsy and pain, taribavirin of the treatment of chronic hepatitis C, and several dermatology candidates for the treatment of rosacea, acne, and dermatological fungus. Valeant Pharmaceuticals International, Inc. is headquartered in Mississauga, Canada.
Valeant Pharmaceuticals International, Inc. (VRX)‘s Financial Overview
Valeant Pharmaceuticals International, Inc. (VRX) surged 1.62% yesterday to close its trading session at $23.81. Valeant Pharmaceuticals International, Inc. has 52-Week high of $24.43 and 52-Week Low of $8.31. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 11.47 Million shares yesterday. The firm shows the market capitalization of $8.34 Billion.
Valeant Pharmaceuticals International, Inc. (VRX) reported its last quarterly earnings on 6/29/2010 where the firm reported its Actual EPS of $0.69/share against the analyst consensus estimate of $0.63/share. The difference between the actual and expected EPS is $0.06 a share with a surprise factor of 9.5%.
The firm is trading with SMA20 of 9.04 Percent, SMA50 of SMA50 Percent and SMA200 of 63.47 percent. Valeant Pharmaceuticals International, Inc. has P/S value of 0.93 while its P/B value stands at 1.57. Similarly, the company has Return on Assets of 3.3 percent, Return on Equity of 33.8 percent and Return on Investment of -1.6 Percent. The company shows Gross Margin and Operating Margin of 71.4 percent and 5.7 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 3 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 18 analysts offering 12-month price forecasts for Valeant Pharmaceuticals International Inc have a median target of 16.00, with a high estimate of 35.00 and a low estimate of 8.00. The median estimate represents a -32.80% decrease from the last price of 23.81.
SeaWorld Entertainment, Inc. (SEAS)
SeaWorld Entertainment, Inc. is a theme park and entertainment company operating primarily in the United States. The company owns and operates U.S. theme parks, including the popular SeaWorld(R), Busch Gardens(R) and Sesame Place(R) brands. SeaWorld Entertainment, Inc. is headquartered in Orlando, Florida.
SeaWorld Entertainment, Inc. (SEAS)‘s Financial Outlook
The 11 analysts offering 12-month price forecasts for SeaWorld Entertainment Inc have a median target of 13.50, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a -9.52% decrease from the last price of 14.92.
According to Zacks Investment Research, SeaWorld Entertainment, Inc. has a Consensus Recommendation of 2.58. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged5.22% and closed its last trading session at $14.92. The company has the market capitalization of $1.33 Billion. The stock has 52-week high of $20.13 and 52-Week low of $10.42. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 6.42 Million shares. The company has a total of 89.06 Million shares outstanding.
SeaWorld Entertainment, Inc. (SEAS) in the last quarter reported its actual EPS of $0.64/share where the analyst estimated EPS was $0.81/share. The difference between the actual and Estimated EPS is $-0.17. This shows a surprise factor of -21 percent.
The company has YTD performance of 9.95 percent. Beta for SeaWorld Entertainment, Inc. stands at 0.79 while its ATR (average true range) is 0.49. The company has Weekly Volatility of 4.03%% and Monthly Volatility of 3.31%.
SeaWorld Entertainment, Inc. has distance from 20-day Simple Moving Average (SMA20) of 10.43%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of 2.96%.
The Company currently has ROA (Return on Assets) of -8.6 percent, Return on Equity (ROE) of -55.2 Percent and Return on Investment (ROI) of 2.5% with Gross margin of 55 percent and Operating & Profit margin of -16.6% and -15.3% respectively.